Logotipo do repositório
 

Publicação:
Mesenchymal stem cell therapy for equine tendinitis

dc.contributor.authorAlves, Ana Liz Garcia [UNESP]
dc.contributor.authorde Mattos Carvalho, Armando [UNESP]
dc.contributor.authorHussni, Carlos Alberto [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:28:44Z
dc.date.available2014-05-27T11:28:44Z
dc.date.issued2013-03-28
dc.description.abstractTendinitis is an important disease that leads to lameness and decreased performance in equine athletes and results in high costs associated with therapy due to a long recovery period and a high rate of recurrence. Although, several treatments for equine tendinitis have been described, few are effective in significantly improving the quality of the extracellular matrix and reducing the rate of recurrence. The use of cell therapy with mesenchymal stem cells (MSCs) derived from various sources has received much attention because of its therapeutic potential for equine tendinitis. In this paper, we review patents on stem cell therapy and the specific use of MSCs for the treatment of equine tendinitis. © 2013 Bentham Science Publishers.en
dc.description.affiliationDepartment of Veterinary Surgery and Anesthesiology School of Veterinary Medicine and Animal Science São Paulo State University (UNESP), Rubião Juniors. número, Botucatu, SP
dc.description.affiliationUnespDepartment of Veterinary Surgery and Anesthesiology School of Veterinary Medicine and Animal Science São Paulo State University (UNESP), Rubião Juniors. número, Botucatu, SP
dc.format.extent103-110
dc.identifierhttp://dx.doi.org/10.2174/2210296511303020002
dc.identifier.citationRecent Patents on Regenerative Medicine, v. 3, n. 2, p. 103-110, 2013.
dc.identifier.doi10.2174/2210296511303020002
dc.identifier.issn2210-2965
dc.identifier.issn2210-2973
dc.identifier.lattes7773733250141398
dc.identifier.lattes6020984937849801
dc.identifier.scopus2-s2.0-84875317890
dc.identifier.urihttp://hdl.handle.net/11449/74892
dc.language.isoeng
dc.relation.ispartofRecent Patents on Regenerative Medicine
dc.rights.accessRightsAcesso restrito
dc.sourceScopus
dc.subjectAdipose tissue
dc.subjectAdult stem cells
dc.subjectBone marrow
dc.subjectCell therapy
dc.subjectEquine
dc.subjectTendinitis
dc.subject5' nucleotidase
dc.subjectbone morphogenetic protein 12
dc.subjectcell marker
dc.subjectendoglin
dc.subjectscatter factor
dc.subjectsomatomedin C
dc.subjectThy 1 antigen
dc.subjectvasculotropin
dc.subjectapoptosis
dc.subjectbone marrow biopsy
dc.subjectcell adhesion
dc.subjectcell proliferation
dc.subjectcell transdifferentiation
dc.subjectextracellular matrix
dc.subjectgene expression
dc.subjecthematopoietic stem cell
dc.subjecthistopathology
dc.subjecthorse
dc.subjecthuman
dc.subjectimmunophenotyping
dc.subjectmesenchymal stem cell transplantation
dc.subjectmultipotent stem cell
dc.subjectnonhuman
dc.subjectpriority journal
dc.subjectrecurrence risk
dc.subjectreview
dc.subjectsarcoma
dc.subjecttendinitis
dc.subjecttissue engineering
dc.subjectwound healing
dc.titleMesenchymal stem cell therapy for equine tendinitisen
dc.typeResenha
dcterms.licensehttp://eurekaselect.com/209
dspace.entity.typePublication
unesp.author.lattes7773733250141398[1]
unesp.author.lattes6020984937849801[3]
unesp.author.orcid0000-0001-9092-7819[1]
unesp.author.orcid0000-0001-5421-2904[3]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina Veterinária e Zootecnia, Botucatupt
unesp.departmentCirurgia e Anestesiologia Veterinária - FMVZpt

Arquivos